Completed NA INTERVENTIONAL 1-arm NCT02964429

Determination In-vivo KUF for Diacap Pro Hemodialyser

Determination of the In-vivo Ultrafiltration Coefficient and Evaluation of Performance, Hemo- and Biocompatibility- and Safety-data of High Flux Hemodialyser Diacap Pro in Patients With End Stage Renal Disease on Chronic Hemodialysis

Sponsor: B.Braun Avitum AG

Conditions Kidney Disease, End-Stage Kidney Failure,Chronic Kidney Insufficiency Renal Insufficiency,Chronic

Interventions Diacap Pro High-Flux

Updated 7 times since 2017 Last updated: Feb 6, 2017 Started: Nov 14, 2016 Primary completion: Dec 23, 2016 Completion: Dec 23, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Kidney Disease, End-Stage and Kidney Failure,Chronic and is currently completed. B.Braun Avitum AG leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

Nov 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

B.Braun Avitum AG
Winicker Norimed GmbH

Data source: B.Braun Avitum AG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Prague, Czechia